Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Biliary Tract Neoplasms × apixaban × 1 year × Clear all

Sponsor

Conditions

Venous Thromboembolism 7 Pulmonary Embolism 3 Neoplasms 3 Venous Thrombosis 2 Multiple Myeloma 2 Hematologic Neoplasms 2 Urinary Bladder Neoplasms 1 Upper Extremity Deep Vein Thrombosis 1 Thromboprophylaxis 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Lymphoma 1 Leukemia 1 Intracranial Thrombosis 1 Fibrosis 1 Embolism 1 Catheter-Related Infections 1 Carcinoma, Hepatocellular 1

Interventions

Gemcitabine 29 Cisplatin 28 durvalumab 17 pembrolizumab 13 Leucovorin 11 Oxaliplatin 10 Fluorouracil 9 Capecitabine 9 Nivolumab 8 lenvatinib 7 Bevacizumab 6 zanidatamab 4 Liquid Biopsy 4 Folfox protocol 4 Carboplatin 4 130-nm albumin-bound paclitaxel 4 tremelimumab 3 tislelizumab 3 irinotecan sucrosofate 3 Trastuzumab 3 S 1 (combination) 3 Injections 3 pertuzumab 2 niraparib 2 ivosidenib 2 gemcitabine-oxaliplatin regimen 2 envafolimab 2 brigimadlin 2 atezolizumab 2 Tegafur 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡